Market Insights
Conventionally, 2D cell culture has been used regularly in laboratories across the world. However, 2D cell culture has evolved and is no longer capable of replicating the exact in vivo environment. With the advent of technology, 3D cell culture models are able to exhibit an environment similar to complex in vivo conditions.
The assembly of living cells in a three-dimensional structure resembling specific tissue and organ microarchitecture is known as 3D cell culture.3D cell culture can be made using scaffolding or scaffold-free methods. 3D cell culture models have a wide range of applications, ranging from tissue engineering to drug development, discovery, and screening.
The report titled “3D Cell Culture Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall 3D cell culture market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on the type of technology, application, and different geographies.
The technology type segment studied for analyzing the overall global 3D cell culture market is majorly segmented into scaffold-free and scaffold-based. Scaffold-free is further sub-segmented as microfluidics, 3D bioreactors, hanging drop plates, 3D Petri dishes, ultra-low attachment plates, magnetic levitations, and 3D Bioprinting.
Scaffold-based materials are also further sub-segmented into hydrogels/ECM analogs, solid scaffolds, and micropatterned surfaces. The application type segment studied for analyzing the overall global 3D cell culture market is majorly segmented into drug discovery, screening, and development, tissue engineering and regenerative medicine, cancer and biotech research, stem cell application, 3D printing microfluidics, and others.
Geographically, the global 3D cell culture market is divided into major regions such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and the GCC countries.
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global 3D cell culture market.
Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global 3D cell culture market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global 3D cell culture market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.
Based on the type of application, the global 3D cell culture market is segmented as follows:
- Drug Discovery, Screening, and Development
- Tissue engineering and regenerative medicine
- Cancer and biotech research
- Stem cell application
- Pneumonia 3D Printing Microfluidics
Cancer cell research dominates the three-dimensional (3D) cell culture market by application. 3D cell culture is widely used in cancer research for its efficacy and safety profiling, as the 3D model mimics the in vivo condition better. 3D cell culture models are good simulators for cancer tumors and exhibit analogous growth patterns and treatment effects.
The next followed-up market is drug discovery, screening, and development due to its advantage over the 2D model in terms of providing more valid physiological information and predictive data from in vivo tests. 3D cell culture plays an important role in tissue engineering and regenerative medicine. Microfluidics technology with a 3D cell culture model has the potential for in vivo tissue-based application in the future.
Based on the type of technology, the global 3D cell culture market is segmented as follows:
Scaffold Free
- Microfluidic
- 3D Bioreactors
- Hanging Drop Plates
- 3D Petri dishes
- Magnetic Levitation and 3D Bioprinting
- Ultra-Low Attachment Plates
Scaffold Based
- Hydrogels/ECM Analogs
- Solid Scaffolds
- Micropatterned Surfaces
The conventionally used scaffold-based cell culture model dominates the 3D cell culture market. The scaffold is made of different materials, which play an important role in tissue engineering. Hydrogel scaffolds are widely used in encapsulation and drug delivery, and as they resemble native tissues due to their water-absorbing characteristics, they are abundant and affordable.
Recently, micropatterning technology has been used for the fundamental biology of cell-ECM interaction. Scaffold-free approaches are emerging as promising elements of a clinical translational pathway for tissue engineering. Microfluidic 3D cell culture has great potential to mimic the complex and dynamic in vivo environment used in the emerging organ-on-a-chip system.
Scaffold-free 3D Bioprinting also better mimics the native tissue in a shorter period of time and is therefore considered promising in the direction of tissue fabrication. With the advent of technology such as hanging drop plates and magnetic levitation, the ultra-low attachment in a scaffold-free model favors future growth in the 3D cell culture market.
For the purpose of this study, the 3D cell culture market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
In 2015, North America dominated the 3D cell culture market due to drivers such as research and development activities in cell culture focusing on oncology, rising awareness of organ transplants, and a favorable regulatory environment. Asia-Pacific is the fastest-growing and most lucrative market in 3D cell culture, especially in Japan, China, India, Malaysia, and Singapore. Emerging economies are becoming lucrative markets with the development of healthcare and biotechnology infrastructure, government funding for R&D in areas such as cell biology, oncology, and drug development, and outsourcing to developing countries.
